pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4254 |
Genomic Coordinates | chr1: 31758660 - 31758735 |
Description | Homo sapiens miR-4254 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4254 | ||||||||||||||||||
Sequence | 44| GCCUGGAGCUACUCCACCAUCUC |66 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | SOLiD | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | BTG2 | ||||||||||||||||||||
Synonyms | APRO1, PC3, TIS21 | ||||||||||||||||||||
Description | BTG anti-proliferation factor 2 | ||||||||||||||||||||
Transcript | NM_006763 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on BTG2 | |||||||||||||||||||||
3'UTR of BTG2 (miRNA target sites are highlighted) |
>BTG2|NM_006763|3'UTR 1 GCCCTTCCGCCCCCGCCCTGGGCGCCGCCGTGCTCATGCTGCCGTGACAACAGGCCACCACATACCTCAACCTGGGGAAC 81 TGTATTTTTAAATGAAGAGCTATTTATATATATTATTTTTTTTTAAGAAAGGAGGAAAAGAAACCAAAAGTTTTTTTTAA 161 GAAAAAAAATCCTTCAAGGGAGCTGCTTGGAAGTGGCCTCCCCAGGTGCCTTTGGAGAGAACTGTTGCGTGCTTGAGTCT 241 GTGAGCCAGTGTCTGCCTATAGGAGGGGGAGCTGTTAGGGGGTAGACCTAGCCAAGGAGAAGTGGGAGACGTTTGGCTAG 321 CACCCCAGGAAGATGTGAGAGGGAGCAAGCAAGGTTAGCAACTGTGAACAGAGAGGTCGGGATTTGCCCTGGGGGAGGAA 401 GAGAGGCCAAGTTCAGAGCTCTCTGTCTCCCCCAGCCAGACACCTGCATCCCTGGCTCCTCTATTACTCAGGGGCATTCA 481 TGCCTGGACTTAAACAATACTATGTTATCTTTTCTTTTATTTTTCTAATGAGGTCCTGGGCAGAGAGTGAAAAGGCCTCT 561 CCTGATTCCTACTGTCCTAAGCTGCTTTTCTTGAAATCATGACTTGTTTCTAATTCTACCCTCAGGGGCCTGTAGATGTT 641 GCTTTCCAGCCAGGAATCTAAAGCTTTGGGTTTTCTGAGGGGGGGGAGGAGGGAACTGGAGGTTATTGGGGTTAGGATGG 721 AAGGGAACTCTGCACAAAACCTTTGCTTTGCTAGTGCTGCTTTGTGTGTATGTGTGGCAAATAATTTGGGGGTGATTTGC 801 AATGAAATTTTGGGACCCAAAGAGTATCCACTGGGGATGTTTTTTGGCCAAAACTCTTCCTTTTGGAACCACATGAAAGT 881 CTTGATGCTGCTGCCATGATCCCTTTGAGAGGTGGCTCAAAAGCTACAGGGAACTCCAGGTCCTTTATTACTGCCTTCTT 961 TTCAAAAGCACAACTCTCCTCTAACCCTCCCCTCCCCCTTCCCTTCTGGTCGGGTCATAGAGCTACCGTATTTTCTAGGA 1041 CAAGAGTTCTCAGTCACTGTGCAATATGCCCCCTGGGTCCCAGGAGGGTCTGGAGGAAAACTGGCTATCAGAACCTCCTG 1121 ATGCCCTGGTGGGCTTAGGGAACCATCTCTCCTGCTCTCCTTGGGATGATGGCTGGCTAGTCAGCCTTGCATGTATTCCT 1201 TGGCTGAATGGGAGAGTGCCCCATGTTCTGCAAGACTACTTGGTATTCTTGTAGGGCCGACACTAAATAAAAGCCAAACC 1281 TTGGGCACTGTTTTTTCTCCCTGGTGCTCAGAGCACCTGTGGGAAAGGTTGCTGTCTGTCTCAGTACAATCCAAATTTGT 1361 CGTAGACTTGTGCAATATATACTGTTGTGGGTTGGAGAAAAGTGGAAAGCTACACTGGGAAGAAACTCCCTTCCTTCAAT 1441 TTCTCAGTGACATTGATGAGGGGTCCTCAAAAGACCTCGAGTTTCCCAAACCGAATCACCTTAAGAAGGACAGGGCTAGG 1521 GCATTTGGCCAGGATGGCCACCCTCCTGCTGTTGCCCCTTAGTGAGGAATCTTCACCCCACTTCCTCTACCCCCAGGTTC 1601 TCCTCCCCACAGCCAGTCCCCTTTCCTGGATTTCTAAACTGCTCAATTTTGACTCAAAGGTGCTATTTACCAAACACTCT 1681 CCCTACCCATTCCTGCCAGCTCTGCCTCCTTTTCAACTCTCCACATTTTGTATTGCCTTCCCAGACCTGCTTCCAGTCTT 1761 TATTGCTTTAAAGTTCACTTTGGGCCCACAGACCCAAGAGCTAATTTTCTGGTTTGTGGGTTGAAACAAAGCTGTGAATC 1841 ACTGCAGGCTGTGTTCTTGCATCTTGTCTGCAAACAGGTCCCTGCCTTTTTAGAAGCAGCCTCATGGTCTCATGCTTAAT 1921 CTTGTCTCTCTTCTCTTCTTTATGATGTTCACTTTAAAAACAACAAAACCCCTGAGCTGGACTGTTGAGCAGGCCTGTCT 2001 CTCCTATTAAGTAAAAATAAATAGTAGTAGTATGTTTGTAAGCTATTCTGACAGAAAAGACAAAGGTTACTAATTGTATG 2081 ATAGTGTTTTTATATGGAAGAATGTACAGCTTATGGACAAATGTACACCTTTTTGTTACTTTAATAAAAATGTAGTAGGA 2161 TAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | MCF7 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760597. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP_C
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_006763 | 3UTR | GCUGCUGCCAUGAUCCCUUUGAGAGGUGGCUCAAAAGCUACAGGGAACUCCAGGUCCUUUAUUACUGCCUUCUUUUCAAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_006763 | 3UTR | UCCCUUUGAGAGGUGGCUCAAAAGCUACAGGGAACUCCAGGUCCUUUAUUACUGCCUUCUUUUCAAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_006763 | 3UTR | UGGCUCAAAAGCUACAGGGAACUCCAGGUCCUUUAUUACUGCCUUCUUUUCAAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_006763 | 3UTR | UGAGAGGUGGCUCAAAAGCUACAGGGAACUCCAGGUCCUUUAUUACUGCCUUCUUUUCAAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_006763 | 3UTR | AUCCCUUUGAGAGGUGGCUCAAAAGCUACAGGGAACUCCAGGUCCUUUAUUACUGCCUUCUUUUCAAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000290551.4 | 3UTR | CUACAGGGAACUCCAGGUCCUUUAUUACUGCCUUCUUUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000290551.4 | 3UTR | AACUCCAGGUCCUUUAUUACUGCCUUCUUUUCAAAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
57 hsa-miR-4254 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT061595 | BTG2 | BTG anti-proliferation factor 2 | 2 | 4 | ||||||||
MIRT306302 | ABCC5 | ATP binding cassette subfamily C member 5 | 2 | 2 | ||||||||
MIRT353697 | ACTR2 | ARP2 actin related protein 2 homolog | 2 | 2 | ||||||||
MIRT442351 | RAB6B | RAB6B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT448535 | RIMS4 | regulating synaptic membrane exocytosis 4 | 2 | 2 | ||||||||
MIRT449881 | CYP3A5 | cytochrome P450 family 3 subfamily A member 5 | 2 | 2 | ||||||||
MIRT457644 | ZNF69 | zinc finger protein 69 | 2 | 2 | ||||||||
MIRT458620 | TRIM72 | tripartite motif containing 72 | 2 | 2 | ||||||||
MIRT470963 | PKM | pyruvate kinase, muscle | 2 | 2 | ||||||||
MIRT476285 | GMFB | glia maturation factor beta | 2 | 10 | ||||||||
MIRT477615 | EFNA3 | ephrin A3 | 2 | 2 | ||||||||
MIRT482761 | TMEM126B | transmembrane protein 126B | 2 | 2 | ||||||||
MIRT492535 | PSMD11 | proteasome 26S subunit, non-ATPase 11 | 2 | 2 | ||||||||
MIRT502995 | CCDC71L | coiled-coil domain containing 71 like | 2 | 8 | ||||||||
MIRT508467 | HOXB6 | homeobox B6 | 2 | 4 | ||||||||
MIRT520190 | WBP2 | WW domain binding protein 2 | 2 | 2 | ||||||||
MIRT525117 | PRKD2 | protein kinase D2 | 2 | 2 | ||||||||
MIRT525773 | SOD2 | superoxide dismutase 2 | 2 | 2 | ||||||||
MIRT526411 | TFAM | transcription factor A, mitochondrial | 2 | 2 | ||||||||
MIRT528152 | AGTPBP1 | ATP/GTP binding protein 1 | 2 | 2 | ||||||||
MIRT534111 | SOGA3 | SOGA family member 3 | 2 | 2 | ||||||||
MIRT538026 | DNAJC10 | DnaJ heat shock protein family (Hsp40) member C10 | 2 | 2 | ||||||||
MIRT539288 | ANGEL2 | angel homolog 2 | 2 | 2 | ||||||||
MIRT541103 | RAF1 | Raf-1 proto-oncogene, serine/threonine kinase | 2 | 2 | ||||||||
MIRT550999 | SUOX | sulfite oxidase | 2 | 2 | ||||||||
MIRT562165 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT570122 | CACNG8 | calcium voltage-gated channel auxiliary subunit gamma 8 | 2 | 2 | ||||||||
MIRT571104 | DENND4B | DENN domain containing 4B | 2 | 2 | ||||||||
MIRT574099 | VASN | vasorin | 2 | 2 | ||||||||
MIRT611153 | ZNF486 | zinc finger protein 486 | 2 | 2 | ||||||||
MIRT612252 | STX1B | syntaxin 1B | 2 | 4 | ||||||||
MIRT614808 | RIOK3 | RIO kinase 3 | 2 | 2 | ||||||||
MIRT622153 | SORBS2 | sorbin and SH3 domain containing 2 | 2 | 2 | ||||||||
MIRT624286 | CRCP | CGRP receptor component | 2 | 2 | ||||||||
MIRT624875 | ABCC12 | ATP binding cassette subfamily C member 12 | 2 | 2 | ||||||||
MIRT627479 | STRN | striatin | 2 | 2 | ||||||||
MIRT641273 | AMDHD2 | amidohydrolase domain containing 2 | 2 | 2 | ||||||||
MIRT645622 | TSPAN6 | tetraspanin 6 | 2 | 2 | ||||||||
MIRT650226 | SIGLEC9 | sialic acid binding Ig like lectin 9 | 2 | 2 | ||||||||
MIRT657507 | HBEGF | heparin binding EGF like growth factor | 2 | 2 | ||||||||
MIRT660811 | AHCY | adenosylhomocysteinase | 2 | 2 | ||||||||
MIRT667439 | METTL14 | methyltransferase like 14 | 2 | 2 | ||||||||
MIRT693744 | ACACA | acetyl-CoA carboxylase alpha | 2 | 2 | ||||||||
MIRT697852 | UBE2Z | ubiquitin conjugating enzyme E2 Z | 2 | 2 | ||||||||
MIRT698719 | SUMO2 | small ubiquitin-like modifier 2 | 2 | 2 | ||||||||
MIRT699980 | RREB1 | ras responsive element binding protein 1 | 2 | 2 | ||||||||
MIRT700689 | POLR3D | RNA polymerase III subunit D | 2 | 2 | ||||||||
MIRT703267 | GNL3L | G protein nucleolar 3 like | 2 | 2 | ||||||||
MIRT703787 | FAM102B | family with sequence similarity 102 member B | 2 | 2 | ||||||||
MIRT711277 | SDR9C7 | short chain dehydrogenase/reductase family 9C member 7 | 2 | 2 | ||||||||
MIRT711863 | TRAF2 | TNF receptor associated factor 2 | 2 | 2 | ||||||||
MIRT712451 | KHNYN | KH and NYN domain containing | 2 | 2 | ||||||||
MIRT714449 | UBXN2A | UBX domain protein 2A | 2 | 2 | ||||||||
MIRT718846 | SNX20 | sorting nexin 20 | 2 | 2 | ||||||||
MIRT721333 | IFNAR2 | interferon alpha and beta receptor subunit 2 | 2 | 2 | ||||||||
MIRT723315 | PRKCH | protein kinase C eta | 2 | 2 | ||||||||
MIRT736659 | CYP2B6 | cytochrome P450 family 2 subfamily B member 6 | 1 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|